MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes

Philipp W. RaessDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA; Correspondence[email protected]

Stephen R. MooreKnight Diagnostic Laboratories, Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA

Michael J. CascioDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA;

Jennifer DunlapDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA;

Guang FanDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA;

Ken GatterDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA;

Susan B. OlsonKnight Diagnostic Laboratories, Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA

Rita M. BrazielDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA;

Your download is now in progress and you may close this window